Zoetis Inc. (ZTS): Revenue
$9.47B
Year ended 2025-12-31
+5.4%
3-year compound annual growth
+7.2%
5-year compound annual growth
+7.1%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.47B | +2.3% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $9.26B | +8.3% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $8.54B | +5.7% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $8.08B | +3.9% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $7.78B | +16.5% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $6.67B | +6.6% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $6.26B | +7.5% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $5.83B | +9.8% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $5.31B | +8.6% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $4.89B | +2.6% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $4.76B | -0.4% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $4.79B | +4.9% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $4.56B | +5.2% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $4.34B | +2.4% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $4.23B | n/a | 2014-03-26, From 2011-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $9.47B | +2.3% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $10.27B | +6.7% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $12.00B | +8.9% |
| Viatris Inc (VTRS) | 2025-12-31 | $14.30B | -3.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $14.34B | +1.0% |
| Organon & Co. (OGN) | 2025-12-31 | $6.22B | -2.9% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $5.34B | +40.2% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $17.26B | +4.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $4.71B | +6.2% |
Compare ZTS, BHC, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗